Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Upgraded to Buy at Wall Street Zen

Key Points

• Bayer Aktiengesellschaft has been upgraded from a "hold" rating to a "buy" rating by Wall Street Zen following previous upgrades from Kepler Capital Markets and Goldman Sachs.
• The company's stock is currently trading at $7.53 with a market capitalization of $29.59 billion and an average rating of "Buy" from analysts.
• Bayer's recent quarterly earnings report showed an EPS of $0.35, surpassing expectations, with revenues of $12.42 billion compared to the consensus estimate of $10.79 billion.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a note issued to investors on Sunday.

BAYRY has been the subject of a number of other research reports. Kepler Capital Markets upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a report on Wednesday, June 11th. The Goldman Sachs Group upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a report on Thursday, June 5th. Finally, Hsbc Global Res raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, June 11th. One analyst has rated the stock with a hold rating, two have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Buy".

Bayer Aktiengesellschaft Stock Performance

OTCMKTS BAYRY traded up $0.13 during midday trading on Friday, hitting $7.53. The company had a trading volume of 753,682 shares, compared to its average volume of 1,183,020. The company has a quick ratio of 0.79, a current ratio of 1.25 and a debt-to-equity ratio of 1.07. The stock has a market cap of $29.59 billion, a price-to-earnings ratio of -7.76 and a beta of 0.91. The firm has a fifty day simple moving average of $7.83 and a two-hundred day simple moving average of $6.74. Bayer Aktiengesellschaft has a fifty-two week low of $4.79 and a fifty-two week high of $8.65.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.35 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.10. Bayer Aktiengesellschaft had a negative net margin of 7.61% and a positive return on equity of 15.48%. The company had revenue of $12.42 billion during the quarter, compared to the consensus estimate of $10.79 billion. Equities analysts forecast that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current fiscal year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.